Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Curr Opin Oncol. 2012 Mar;24(2):182–190. doi: 10.1097/CCO.0b013e32834f5c41

Table 1.

High-risk prognostic features for adult ALL

B-ALL T-ALL
At Diagnosis
Age >35
WBC >30 × 109 >100 × 109
Cytogenetics t(9;22), t(4;11), −7, +8, t(8;14)
Hypodiploidy
t(1;19)*
Complex cytogenetics
Molecular genetics BCR-ABL
IKAROS
BAALC+
BAALC+
HOX11L2
ERG+
Immunophenotype Pro B
CD10-neg pre-B
CD20
Early T
Mature T
After Induction
Time to CR1 > 4 weeks
MRD > 10−4
Clinical Relapse > CR1
*

Recent report by Burmeister et. al [10]. shows no adverse prognosis with t(1;19)

WBC = white blood cell count, MRD = minimal residual disease, CR1= First complete remission